REFERENCES
1 Liu Z, Doan Q V., Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Heal. 2007; 10 : 183–94.
2 Karlsson TS, Marions LB, Edlund MG. Heavy menstrual bleeding significantly affects quality of life. Acta Obstet Gynecol Scand2014; 93 : 52–7.
3 Duckitt K. Managing perimenopausal menorrhagia. Maturitas. 2010;66 : 251–6.
4 Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynecol Obstet 2015;128 : 196–200.
5 Munro MG, Critchley HOD, Fraser IS, et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet 2018. DOI:10.1002/ijgo.12666.
6 National Collaborating Centre for W, Children’s H. National Institute for Health and Clinical Excellence: Guidance. In: Heavy Menstrual Bleeding. 2007.
7 Marret H, Fauconnier A, Chabbert-Buffet N, et al. Clinical practice guidelines on menorrhagia: Management of abnormal uterine bleeding before menopause. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010;152 : 133–7.
8 Cooper K, Lee AJ, Chien P, Raja EA, Timmaraju V, Bhattacharya S. Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: Retrospective analysis of hospital episode statistics in Scotland. BJOG An Int J Obstet Gynaecol 2011. DOI:10.1111/j.1471-0528.2011.03011.x.
9 Kroft J, Liu G. First-Versus Second-Generation Endometrial Ablation Devices for Treatment of Menorrhagia: A Systematic Review, Meta-Analysis and Appraisal of Economic Evaluations. J Obstet Gynaecol Canada2013; 35 : 1010–9.
10 Lethaby A, Penninx J, Hickey M, Garry R, Marjoribanks J. Endometrial resection and ablation techniques for heavy menstrual bleeding. Cochrane Database Syst. Rev. 2013; 2013 . DOI:10.1002/14651858.CD001501.pub4.
11 Daniels JP, Middleton LJ, Champaneria R, et al. Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis. BMJ. 2012; 344 . DOI:10.1136/bmj.e2564.
12 Cooper K, McCormack K, Breeman S, et al. HEALTH: Laparoscopic supracervical hysterectomy versus second-generation endometrial ablation for the treatment of heavy menstrual bleeding: Study protocol for a randomised controlled trial. Trials 2018. DOI:10.1186/s13063-017-2374-9.
13 Fernandez H, Kobelt G, Gervaise A. Economic evaluation of three surgical interventions for menorrhagia. Hum Reprod 2003;18 : 583–7.
14 Cooper K, Breeman S, Scott NW, et al. Laparoscopic supracervical hysterectomy compared with second-generation endometrial ablation for heavy menstrual bleeding: The HEALTH RCT. Health Technol Assess (Rockv) 2019. DOI:10.3310/hta23530.
15 Roberts TE, Tsourapas A, Middleton LJ, et al. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: Cost effectiveness analysis. In: BMJ (Online). 2011. DOI:10.1136/bmj.d2202.
16 Garside R, Stein K, Wyatt K, Round A, Pitt M. A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG An Int J Obstet Gynaecol 2004; 111 : 1103–14.
17 Bischoff-Everding C, Soeder R, Neukirch B. Economic and clinical benefits of endometrial radiofrequency ablation compared with other ablation techniques in women with menorrhagia: A retrospective analysis with German health claims data. Int J Womens Health 2016;8 : 23–9.
18 Miller JD, Lenhart GM, Bonafede MM, Basinski CM, Lukes AS, Troeger KA. Cost effectiveness of endometrial ablation with the NovaSure® system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and medicaid payer perspectives. Int J Womens Health 2015; 7 : 59–73.
19 Bezin J, Duong M, Lassalle R, et al. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology. Pharmacoepidemiol Drug Saf 2017;26 : 954–62.
20 WHO. International Statistical Classification of Diseases and Related Health Problems (International Classification of Diseases)(ICD) 10th Revision - Version:2010. 2010.
21 de Léotoing L, Chaize G, Fernandes J, et al. The surgical treatment of idiopathic abnormal uterine bleeding: An analysis of 88 000 patients from the French exhaustive national hospital discharge database from 2009 to 2015. PLoS One 2019. DOI:10.1371/journal.pone.0217579.